Vitamin D supplementation, with or without omega-3 fatty acids, linked to reduced risk for autoimmune disease
Skyrizi Approved for Psoriatic Arthritis
Approval based on two Phase 3 trials showing more than 50 percent of patients receiving Skyrizi achieved ACR20 response at 24 weeks
Self-Help Aids Quality of Life for People With Psoriasis
Findings show modest, but significant, benefit from either compassion-based or mindfulness-based self-help
Risk for Cancer Increased After VTE for Patients With Psoriasis
Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
Increased market growth of biosimilars that are similar to brand-name biologic agents has the potential to reduce spending on prescription drugs
COVID-19 Proning Teams Benefit From Wound Care Specialist Nurse
Findings show inclusion significantly cuts odds of pressure injuries in patients hospitalized with severe COVID-19
FDA Approves Rinvoq for Treatment of Atopic Dermatitis
Approval indicated for those 12 years and older with atopic dermatitis that has not responded to previous treatment
Specialist-Led Model of Care Can Improve CVD Prevention in Psoriasis
Dermatologists and patients with psoriatic disease approve of a specialist-led model of care
Depression Up in Pediatric, Adult Hidradenitis Suppurativa Patients
Prevalence of depression increased among adults and children with hidradenitis suppurativa
Supreme Court Hears Arguments on Biden’s Vaccine Mandate for Big Business
Court also hearing arguments on separate vaccine mandate for most heath care workers